Transgene in a nutshell Download (PDF)
Category: Tools-Home
esmo
ESMO 2022 Transgene presented exciting preclinical data on TG6050, an intravenous Invir.IO® oncolytic virus Donwload Press release (PDF) TG6002 en images
Home news plugin
innovation box
Innovative technologies Push the boundaries of immunotherapy Transgene combines cutting-edge technologies, a multidisciplinary team and a prestigious international network. Discover our two therapeutic approaches Discover our technologies
TG4001 box
TG4001 A therapeutic vaccine in Phase II TG4001 targets HPV-induced anogenital cancers. More information
myvac-box
One patient, one cancer, one vaccine With myvac®, Transgene enters the field of individualized immunotherapies with a unique virus-based immunotherapy platform. myvac® video Discover myvac®
invirio-box
A new generation of products These innovative multifunctional OVs are able to modulate the tumor micro-environment to better attack cancer. Discover invir.IO®
Corporate presentation
Corporate Presentation Download (PDF)